Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases - authors' reply.
about
Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases - authors' reply.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Editorial: CT-P13, a biosimila ...... wel diseases - authors' reply.
@en
Editorial: CT-P13, a biosimila ...... wel diseases - authors' reply.
@nl
type
label
Editorial: CT-P13, a biosimila ...... wel diseases - authors' reply.
@en
Editorial: CT-P13, a biosimila ...... wel diseases - authors' reply.
@nl
prefLabel
Editorial: CT-P13, a biosimila ...... wel diseases - authors' reply.
@en
Editorial: CT-P13, a biosimila ...... wel diseases - authors' reply.
@nl
P2093
P2860
P356
P1476
Editorial: CT-P13, a biosimila ...... owel diseases - authors' reply
@en
P2093
P2860
P356
10.1111/APT.14060
P407
P577
2017-05-01T00:00:00Z